about
Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerBiomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosisSurveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review.Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE studyPopulation-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology StudyLate tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study.Synchronous and metachronous breast malignancies: a cross-sectional retrospective study and review of the literature.Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationBreast density and parenchymal texture measures as potential risk factors for Estrogen-Receptor positive breast cancer.Recent BRCAPRO upgrades significantly improve calibration.Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.Synchronous uterine carcinosarcoma and contralateral breast cancer after tamoxifen therapy: a case reportOptions for early breast cancer follow-up in primary and secondary care - a systematic review.Relationship between diabetes and risk of second primary contralateral breast cancer.Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.Separate and combined analysis of successive dependent outcomes after breast-conservation surgery: recurrence, metastases, second cancer and death.Concurrent breast stroma sarcoma and breast carcinoma: a case report.Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer.Risk of contralateral second primary breast cancer according to hormone receptor status in Germany.Mammoplasty for symmetry in breast reconstruction and histologic assessment.Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry studyContralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysisBilateral synchronous carcinoma breast- a rare case presentationBisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancerAssessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumourLong-term prognosis of breast cancer detected by mammography screening or other methodsFrom observation to intervention: development of a psychoeducational intervention to increase uptake of BRCA genetic counseling among high-risk breast cancer survivorsBreast magnetic resonance imaging (MRI) surveillance in breast cancer survivorsOutcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis.Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer.Patterns of metastasis in women with metachronous contralateral breast cancer.Estrogen withdrawal, increased breast cancer risk and the KRAS-variant.Pathobiological features of breast tumours in the State of Kuwait: a comprehensive analysis.Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.Second primary malignancies in patients with male breast cancer.
P2860
Q24796391-50454FBB-4B27-4687-9558-23A7EA1791CEQ26738987-1B923560-CB96-4592-8B44-C409D554A006Q28280822-30D08793-9BE8-4F03-BC67-B3A6B9E52C72Q30395721-225A7248-C562-44F9-BCC1-F5BF4F505643Q30415050-A78E45A6-C3E3-4E5F-967D-6E4553FED9E5Q30423128-78504030-F06F-4130-A32C-8CAEE7C3AF0CQ30432062-089035E2-F228-4294-B284-06AC39081EDEQ30432372-8B10E10A-E512-476B-B280-57B3D3E17491Q30436439-42017691-8835-4C92-931A-AB88F79BD788Q33578242-AB99687C-538B-41A7-8F9A-9F3A3F6E8A2EQ33616735-F13EC4BC-8C00-4674-BCE6-D79B9AE90B3EQ33919320-F1A3A883-676C-4F4C-9973-530663733247Q33954899-DD1AC571-F166-474E-A4FD-FEF9AB272D7AQ33992404-B2783CFE-FF5A-4363-8CF2-2C42B0C44E6EQ34088422-60645196-6210-433A-BF0B-834CC625CAEEQ34121698-9E3358C9-ED14-45A4-AC13-FD494AA0639DQ34303226-F2A7BC4D-CF1C-40C0-BC9B-5C89A21BE42BQ34424031-879FDC41-7E3B-4199-BD0C-7EC4618D0596Q34441602-96196787-1959-4D90-ACE6-D0A5A03E0FF1Q34480625-8F73B930-46E9-4040-92EB-9882CFCC2E65Q34482048-7581EA89-2AE2-4AC5-A2D3-8F25AD999094Q34499051-2AD80C9E-C13C-479A-9368-A7C2F88050F0Q34582515-E60133DB-91F0-48B5-84BF-F735E1C89472Q35000330-C0016E98-B9F8-4555-AA81-72637C9C8905Q35014403-C5E2FAB2-00E9-4C25-9010-2BB1D05F6682Q35151141-E5CFCE6B-BE92-4DEE-928B-97ECD315CA60Q35192288-BD80F9C0-7B96-4252-9CE7-177DEB1B675DQ35533650-1C1886C1-DC6D-4EC4-96CD-2D3634BBFE95Q35596736-227F1A0A-84FB-4250-B818-1CFFDA5562BAQ35801963-93C3C6CF-A335-4588-B9D0-F99BE4CC05A7Q35889678-093BD6C8-ACD6-4E7F-8A90-535FDFC3630FQ35939791-2212F2C2-CBA5-49A8-9A50-C11CB5922D61Q35998644-7DD67E43-49CB-4DCE-BEE0-D23F0CFAB312Q36000244-FDBDEFCE-689B-4BE5-A8CF-4BFF74986D98Q36029475-E3092E88-5A00-4D43-BD26-76C35831F755Q36090008-2F92D77D-1E1C-43C3-B259-26A1C69CB695Q36187913-1E06DE55-A7ED-4DC7-80B3-05785D24458FQ36316069-196AAA45-72D2-4D4D-98CC-642984FC5930Q36615813-35B86547-1062-440B-8B92-EFA1A8BF1B9EQ36616590-0CA3FEEB-E85E-4948-982E-B56C549B72FF
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Epidemiology of contralateral breast cancer.
@ast
Epidemiology of contralateral breast cancer.
@en
type
label
Epidemiology of contralateral breast cancer.
@ast
Epidemiology of contralateral breast cancer.
@en
prefLabel
Epidemiology of contralateral breast cancer.
@ast
Epidemiology of contralateral breast cancer.
@en
P2093
P1476
Epidemiology of contralateral breast cancer.
@en
P2093
P304
P577
1999-10-01T00:00:00Z